The Soluble BCMA CAR Sandwich ELISA Kit quantitatively measures the extracellular domain of BCMA-specific CAR shed into human serum, plasma and culture supernatant. It supports exposure and persistence monitoring of BCMA CAR-T therapy in multiple myeloma.
| Analyte / Target | Soluble BCMA CAR (CAR ectodomain shed from anti-BCMA scFv CAR) |
|---|
| Species Reactivity | Human |
|---|
| Assay Type | Quantitative sandwich ELISA (capture anti-CAR mAb + biotinylated target antigen) |
|---|
| Detection Method | Colorimetric, TMB substrate; absorbance read on a standard microplate reader |
|---|
| Sample Type | Human serum, plasma (EDTA / heparin) and cell culture supernatant |
|---|
| Kit Components | 96-well strip plate pre-coated with anti-CAR capture mAb; lyophilized recombinant target-antigen standard; biotinylated target antigen (detection); streptavidin-HRP; sample diluent; concentrated wash buffer; TMB substrate; stop solution; plate sealer |
|---|
| Plate Format | 96-well, 12 × 8 removable strips, pre-coated and ready to use |
|---|
| Assay Workflow | Single-day bench workflow: sample / standard incubation, wash, biotinylated antigen, streptavidin-HRP, TMB substrate and stop. Compatible with standard manual and automated microplate washers. |
|---|
| Performance | A broad quantitative working range is covered by an eight-point standard curve with 4-PL data reduction, and the assay is tuned to the levels of shed CAR typically found in serum, plasma and culture supernatant. Reproducibility within and between runs is carefully controlled, spike recovery in serum, plasma and culture medium is acceptable, and samples behave linearly on dilution, so concentrated samples can be diluted into the working range with confidence. Detailed performance data are documented per lot in the Certificate of Analysis. |
|---|
| Specificity | Recognizes the BCMA-binding ectodomain of BCMA CAR; no cross-reactivity with human IgG / Fc, recombinant BCMA, or CARs of unrelated specificity (CD19, CD20, HER2, GPC3). |
|---|
| Storage & Stability | Store at 2–8 °C; the coated plate must not be frozen. Kit reagents are stable until the expiry date printed on the label. |
|---|
| Application | Quantification of soluble BCMA CAR in patient serum / plasma for myeloma CAR-T PK-PD; supernatant CAR expression QC. |
|---|
| Products description | BCMA (TNFRSF17) is expressed almost exclusively on plasma cells and is the leading validated target for multiple myeloma CAR-T therapy. Serum BCMA itself is a well-recognized disease biomarker, and soluble BCMA CAR adds a direct measure of CAR-T exposure in the same sample matrix. The kit captures soluble BCMA CAR with an anti-CAR antibody and detects it with biotinylated BCMA antigen, providing an antigen-competent readout. Applications include PK-PD sampling in myeloma trials, correlation with M-protein and serum BCMA responses, and CAR expression QC in manufacturing supernatants. |
|---|